Naomi Takino

Shimotsuke, 3290498, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Less Invasive Light Irradiation Methods for Inner Ear Gene Therapy Based on Photoswitch Technology: Toward Clinical Translation.

Less Invasive Light Irradiation Methods for Inner Ear Gene Therapy Based on Photoswitch Technology: Toward Clinical Translation.

Journal: Human gene therapy

Published: February 04, 2026

Optimized AAV vector enables potent therapeutic rescue of inherited glycosylphosphatidylinositol deficiency in mice.

Optimized AAV vector enables potent therapeutic rescue of inherited glycosylphosphatidylinositol deficiency in mice.

Journal: Molecular therapy. Advances

Published: January 05, 2026

AAV-based gene therapy with modified HEXB confers lasting therapeutic benefits in GM2 gangliosidosis models.

AAV-based gene therapy with modified HEXB confers lasting therapeutic benefits in GM2 gangliosidosis models.

Journal: Cell reports. Medicine

Published: September 26, 2025

Enhanced Cochlear Transduction by AAV9 with High-Concentration Sucrose.

Enhanced Cochlear Transduction by AAV9 with High-Concentration Sucrose.

Journal: Human gene therapy

Published: August 29, 2023

Early distribution of18 F-labeled AAV9 vectors in the cerebrospinal fluid after intracerebroventricular or intracisternal magna infusion in non-human primates.

Early distribution of18 F-labeled AAV9 vectors in the cerebrospinal fluid after intracerebroventricular or intracisternal magna infusion in non-human primates.

Journal: The journal of gene medicine

Published: June 22, 2022

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies.

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies.

Journal: Scientific reports

Published: September 18, 2020

Intra-cisterna magna delivery of an AAV vector with the GLUT1 promoter in a pig recapitulates the physiological expression of SLC2A1.

Intra-cisterna magna delivery of an AAV vector with the GLUT1 promoter in a pig recapitulates the physiological expression of SLC2A1.

Journal: Gene therapy

Published: July 01, 2020

Alzheimer Aβ Assemblies Accumulate in Excitatory Neurons upon Proteasome Inhibition and Kill Nearby NAKα3 Neurons by Secretion.

Alzheimer Aβ Assemblies Accumulate in Excitatory Neurons upon Proteasome Inhibition and Kill Nearby NAKα3 Neurons by Secretion.

Journal: iScience

Published: April 25, 2018

Gene therapy for Glut1-deficient mouse using an adeno-associated virus vector with the human intrinsic GLUT1 promoter.

Gene therapy for Glut1-deficient mouse using an adeno-associated virus vector with the human intrinsic GLUT1 promoter.

Journal: The journal of gene medicine

Published: December 20, 2017

Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease.

Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease.

Journal: Human gene therapy. Clinical development

Published: March 11, 2017

Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome.

Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome.

Journal: Molecular genetics and metabolism reports

Published: October 18, 2016

Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.

Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 31, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026